Keyphrases
Young Adulthood
100%
Older Adults
85%
Body Mass Index
79%
ST-elevation Myocardial Infarction (STEMI)
60%
Pharmacovigilance
60%
Confidence Interval
54%
Hazard Ratio
54%
Hypertension
52%
Non-associated
47%
Safety Profile
45%
Blood Pressure
45%
Young-onset Hypertension
45%
Population-based Retrospective Cohort Study
44%
First Trimester
43%
Adjusted Odds Ratio
40%
Stroke in the Young
40%
Autonomous Cortisol Secretion
40%
National Cohort Study
37%
Systolic Blood Pressure
34%
Major Malformations
32%
Ischemic Stroke
30%
Dexamethasone Suppression Test
30%
Pregnancy Trimester
29%
Military Service
29%
Malformation
26%
Major Congenital Malformations
26%
Chronic Kidney Disease
26%
Reporting Odds Ratio
26%
Angiotensin Receptor Blockers
25%
Propensity Score Matching
24%
Adjusted Hazard Ratio
24%
During Pregnancy
24%
Metabolic Syndrome
23%
Dysglycemia
23%
Metabolic Derangements
22%
Myocardial Infarction Patients
22%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
22%
Sensitivity Analysis
22%
Israeli Adolescents
21%
Estimated Glomerular Filtration Rate
20%
Spina Bifida
20%
Low Body Weight
20%
Normetanephrine
20%
Non-coronary
20%
Early Invasive Strategy
20%
Early Renal Injury
20%
Urinary Tract Cancer
20%
Academic Productivity
20%
Heart Failure Patients
20%
Temporal Perception
20%
Medicine and Dentistry
Hazard Ratio
58%
Body Mass Index
53%
Odds Ratio
46%
Non ST Segment Elevation Myocardial Infarction
40%
Chronic Kidney Disease
40%
Hydrocortisone Release
40%
Congenital Malformation
36%
Myocardial Infarction
35%
Retrospective Cohort Study
33%
First Trimester Pregnancy
32%
Hydrocortisone
30%
Dexamethasone Suppression Test
30%
Cohort Analysis
27%
Blood Pressure
22%
Dysglycemia
22%
Kidney Injury
21%
Propensity Score Matching
21%
Proportional Hazards Model
20%
Normetanephrine
20%
Metanephrine
20%
Catecholamine
20%
Clonidine
20%
Sodium Glucose Cotransporter 2 Inhibitor
20%
Apoplexy
20%
Enkephalinase Inhibitor
20%
Hematuria
20%
Pharmacovigilance
20%
COVID-19
20%
Systolic Blood Pressure
20%
End Stage Renal Disease
20%
Frailty
20%
Blood Pressure Reduction
20%
Omicron Coronavirus Variant
20%
Urinary Tract Cancer
20%
Myocarditis
20%
Adrenal Adenoma
20%
Angiotensin Receptor Antagonist
20%
Ejection Fraction
20%
Ganglioneuroma
20%
Maturity Onset Diabetes of the Young
20%
Heart Ventricle Remodeling
20%
Cancer
20%
Nonalcoholic Fatty Liver
20%
Pyrrole Derivative
20%
Vagina Candidiasis
20%
Congestive Heart Failure
20%
Spinal Dysraphism
20%
Diseases
19%
Glomerular Filtration Rate
18%
Noradrenalin
17%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
91%
Pharmacovigilance
60%
Congenital Malformation
59%
Non ST Segment Elevation Myocardial Infarction
40%
Hydrocortisone
40%
Heart Infarction
35%
Diseases
30%
Angiotensin Receptor Antagonist
26%
Congestive Heart Failure
23%
Cross-Sectional Study
22%
Sodium Glucose Cotransporter 2 Inhibitor
22%
Dexamethasone
22%
Kidney Injury
21%
Adverse Event
21%
Enkephalinase Inhibitor
20%
Pyrrole Derivative
20%
Amoxicillin
20%
Myocarditis
20%
Catecholamine
20%
Enoxaparin
20%
End Stage Renal Disease
20%
Coronavirinae
20%
Vagina Candidiasis
20%
Heart Ventricle Remodeling
20%
Valsartan/Sacubitril
20%
Frailty
20%
Normetadrenalin
20%
Metadrenalin
20%
Clavulanic Acid
20%
Chronic Kidney Failure
20%
Renal Diabetes
20%
Dysglycemia
20%
Clonidine
20%
Cardiovascular Risk
20%
Adrenal Cortex Adenoma
20%
Amiodarone
20%
Cerebrovascular Accident
20%
Spinal Dysraphism
20%
Noradrenalin
17%
Population Study
15%
Hypotension
14%
All Cause Mortality
13%
Acute Kidney Failure
12%
Metabolic Syndrome X
12%
Infection
10%
Brain Ischemia
10%
Angioneurotic Edema
10%
Hyperkalemia
10%
Adrenal Incidentaloma
10%
Disproportionality Analysis
8%
